Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Harter

Showing results (31-40 of 205) with videos related to

Pageof 21
Sort By:
NMR in Biomedicine|November 21, 2018
Fitting algorithms and baseline correction influence the results of non-invasive in vivo quantitation of 2-hydroxyglutarate with <sup>1</sup> H-MRSKatharina J Wenger, Elke Hattingen, Patrick N Harter, et al.
Molecular Cancer|February 4, 2015
β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastomaJenny Zinke, Fabian T Schneider, Patrick N Harter, et al.
Journal of Neuro-Oncology|February 19, 2014
Benefit of tumor resection for recurrent glioblastomaJohanna Quick, Florian Gessler, Stephan Dützmann, et al.
Acta Neuropathologica|November 12, 2010
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphologyDavid Capper, David Reuss, Jens Schittenhelm, et al.
Oncotarget|November 18, 2015
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?Maximilian Niyazi, Patrick N Harter, Elke Hattingen, et al.
Oncology Letters|June 22, 2018
Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumorsLukas Jennewein, Georg Bartsch, Kilian Gust, et al.
Acta Neurochirurgica|January 30, 2019
Influence of pregnancy on glioma patientsMarie-Therese Forster, Peter Baumgarten, Florian Gessler, et al.
International Journal of Cancer|September 19, 2014
Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMTKai Doberstein, Patrick N Harter, Uwe Haberkorn, et al.
Neurosurgical Focus|January 1, 2021
Neurotoxicity of subarachnoid Gd-based contrast agent accumulation: a potential complication of intraoperative MRI?Monika Lauer, Arne Lauer, Se-Jong You, et al.
Acta Neurochirurgica|March 26, 2026
Quality-of-life and detailed functional outcome after IONM-aided microsurgical resection of cervical and thoracic intramedullary spinal cord tumors in adultsSebastian Siller, Sylvain Duell, Deniz Reyhaniye, et al.
Pageof 21

Showing results (31-40 of 205) with videos related to

Sort By:
Pageof 21
NMR in Biomedicine|November 21, 2018
Fitting algorithms and baseline correction influence the results of non-invasive in vivo quantitation of 2-hydroxyglutarate with <sup>1</sup> H-MRSKatharina J Wenger, Elke Hattingen, Patrick N Harter, et al.
Molecular Cancer|February 4, 2015
β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastomaJenny Zinke, Fabian T Schneider, Patrick N Harter, et al.
Journal of Neuro-Oncology|February 19, 2014
Benefit of tumor resection for recurrent glioblastomaJohanna Quick, Florian Gessler, Stephan Dützmann, et al.
Acta Neuropathologica|November 12, 2010
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphologyDavid Capper, David Reuss, Jens Schittenhelm, et al.
Oncotarget|November 18, 2015
Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?Maximilian Niyazi, Patrick N Harter, Elke Hattingen, et al.
Oncology Letters|June 22, 2018
Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumorsLukas Jennewein, Georg Bartsch, Kilian Gust, et al.
Acta Neurochirurgica|January 30, 2019
Influence of pregnancy on glioma patientsMarie-Therese Forster, Peter Baumgarten, Florian Gessler, et al.
International Journal of Cancer|September 19, 2014
Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMTKai Doberstein, Patrick N Harter, Uwe Haberkorn, et al.
Neurosurgical Focus|January 1, 2021
Neurotoxicity of subarachnoid Gd-based contrast agent accumulation: a potential complication of intraoperative MRI?Monika Lauer, Arne Lauer, Se-Jong You, et al.
Acta Neurochirurgica|March 26, 2026
Quality-of-life and detailed functional outcome after IONM-aided microsurgical resection of cervical and thoracic intramedullary spinal cord tumors in adultsSebastian Siller, Sylvain Duell, Deniz Reyhaniye, et al.
Pageof 21